GLYCERYL MONOSTEARATE

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
359.0 5.1 2 4 67.0 19 0.95
CAS
31566311
UNII
230OU9XXE4
SYNONYMS
ZINC ID(s)
Availability
Present in 36 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Dosages

Route Formulation Per Unit Dose
Auricular (otic) Suspension 0.5%
Dental Paste 64MG
Ophthalmic Suspension 0.5%
Oral Capsule, Delayed Action 0.2MG
Oral Capsule, Delayed Action 1.9MG
Oral Capsule, Hard Gelatin 13.75MG
Oral Capsule, Sustained Action 27MG
Oral Granule, For Oral Suspension 1.9MG
Oral Pellet 1.9MG
Oral Tablet 0.3MG
Oral Tablet 5.6MG
Oral Tablet (immed./comp. Release), Uncoated, Chewable 0.25MG
Oral Tablet, Delayed Action 1.4MG
Oral Tablet, Delayed Action, Enteric Coated 0.01MG
Oral Tablet, Extended Release 17MG
Oral Tablet, Extended Release 0.52MG
Oral Tablet, Orally Disintegrating, Delayed Release 7.5MG
Oral Tablet, Sustained Action 34MG
Oral Tablet, Sustained Action 154MG
Oral Tablet, Sustained Action, Film Coated 264.3MG
Rectal Suppository 35MG
Rectal Suppository 32.3MG
Sublingual Tablet 1.23MG
Topical Cream 2.5%W/W
Topical Cream, Emulsion, Sustained Release 8.5%W/W
Topical Cream, Emulsion, Sustained Release 5%W/W
Topical Emulsion, Aerosol Foam
Topical Emulsion, Cream 10%W/W
Topical Emulsion, Cream 20%
Topical Lotion 3%
Topical Lotion 0.5%W/W
Topical Lotion 9%
Topical Ointment 5%
Topical Suppository 5%
Topical Suspension 1.25%
Vaginal Cream, Emulsion, Sustained Release 1%
Vaginal Emulsion, Cream 17%

More Information

Usage Over Time

Comments